Topics

High-grade gliomas | Treatment | Targeted therapy | PARP inhibitors

Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > PARP inhibitors

Rashidi F, Sabahi M, Allahdadi A, Delbari P, Habibi MA, Tavani SF, Zare A, Sattari SA, Alomari S, Mofatteh M, Mashayekhi MS, Shahjouei S, Ranjan S, Adada B, Chamoun RB, Borghei-Razavi H.
The efficacy and safety of poly ADP-ribose polymerase (PARP) inhibitors in patients with high-grade glioma (HGG): A systematic review and meta-analysis.
J Neuroimmunol. 2026 Jul 4;419:579021. doi: 10.1016/j.jneuroim.2026.579021. PMID: 42424804. ˍ